NCT07402863

Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc)

Self-Guided Resilience-Building Energy Management to Enhance Well-being Intervention for People With Systemic Sclerosis: A Feasibility Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: University of Michigan · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to gather information on the RENEW app used by people with scleroderma. Specifically, the researchers want to learn more about RENEW by collecting information about the rates of recruitment, retention of study participants information about study completion, and time spent accessing the app content.

Detailed description

RENEW is Institutional Review Board approved as a non-significant risk device but it not subject to 510(k) and therefore not regulated by the FDA.

Conditions

• Systemic Sclerosis

Interventions

Type	Name	Description
DEVICE	RENEW	The RENEW program is 12-week program where participants are asked to access the app and set and track weekly healthy goals.

Timeline

• Start date: 2025-01-28
• Primary completion: 2025-04-28
• Completion: 2025-07-28
• First posted: 2026-02-11
• Last updated: 2026-02-11

Locations

1 site across 1 country: United States